Koninklijke Philips Gross Profit 2010-2025 | PHG

Koninklijke Philips annual/quarterly gross profit history and growth rate from 2010 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Koninklijke Philips gross profit for the quarter ending March 31, 2025 was $1.948B, a 3.34% increase year-over-year.
  • Koninklijke Philips gross profit for the twelve months ending March 31, 2025 was $8.435B, a 6.78% increase year-over-year.
  • Koninklijke Philips annual gross profit for 2024 was $8.411B, a 4.34% increase from 2023.
  • Koninklijke Philips annual gross profit for 2023 was $8.061B, a 6.35% increase from 2022.
  • Koninklijke Philips annual gross profit for 2022 was $7.58B, a 10.62% decline from 2021.
Koninklijke Philips Annual Gross Profit
(Millions of US $)
2024 $8,411
2023 $8,061
2022 $7,580
2021 $8,480
2020 $10,031
2019 $9,940
2018 $10,101
2017 $9,246
2016 $11,743
2015 $10,944
2014 $10,908
2013 $12,869
2012 $12,101
2011 $12,044
2010 $12,677
2009 $11,267
Koninklijke Philips Quarterly Gross Profit
(Millions of US $)
2025-03-31 $1,948
2024-09-30 $2,206
2024-06-30 $2,142
2023-06-30 $2,139
2023-03-31 $1,885
2022-06-30 $1,843
2021-06-30 $2,156
2020-06-30 $2,016
2019-06-30 $2,389
2018-06-30 $2,392
2017-06-30 $2,118
2016-12-31 $3,472
2016-09-30 $2,904
2016-06-30 $2,867
2016-03-31 $2,500
2015-12-31 $3,101
2015-09-30 $2,695
2015-06-30 $2,760
2015-03-31 $2,388
2014-12-31 $2,730
2014-09-30 $2,422
2014-06-30 $2,991
2014-03-31 $2,766
2013-12-31 $3,906
2013-09-30 $3,122
2013-06-30 $3,065
2013-03-31 $2,775
2012-12-31 $3,851
2012-09-30 $3,265
2012-06-30 $2,509
2012-03-31 $2,783
2011-12-31 $2,950
2011-09-30 $2,735
2011-06-30 $2,940
2011-03-31 $3,301
2010-12-31 $3,754
2010-09-30 $3,011
2010-06-30 $2,911
2010-03-31 $3,019
2009-12-31 $5,210
2009-09-30 $2,898
2009-06-30 $1,586
2009-03-31 $2,148
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $21.242B $19.503B
Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $230.372B 27.70
Boston Scientific (BSX) United States $149.971B 37.54
Stryker (SYK) United States $142.469B 29.79
EssilorLuxottica (ESLOY) France $128.310B 0.00
Medtronic (MDT) Ireland $109.952B 15.59
Lonza Group Ag (LZAGY) Switzerland $49.265B 0.00
Haleon (HLN) United Kingdom $47.015B 26.80
ResMed (RMD) United States $36.786B 27.63
GE HealthCare Technologies (GEHC) United States $32.917B 15.63
Agilent Technologies (A) United States $32.815B 21.39
Terumo (TRUMY) Japan $26.606B 34.56
Insulet (PODD) United States $21.238B 83.37
Zimmer Biomet Holdings (ZBH) United States $17.915B 11.51
Baxter (BAX) United States $15.293B 11.42
Smith & Nephew SNATS (SNN) United Kingdom $12.517B 0.00
Demant (WILYY) Denmark $9.110B 0.00
Sunny Optical Technology (SNPTF) China $9.087B 0.00
Bio-Rad Laboratories (BIO) United States $6.313B 21.97
Lantheus Holdings (LNTH) United States $5.465B 13.78
Prestige Consumer Healthcare (PBH) United States $4.133B 18.46
Perrigo (PRGO) Ireland $3.618B 9.17
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.366B 15.33
ICU Medical (ICUI) United States $3.165B 23.34
Envista Holdings (NVST) United States $3.154B 26.21
GN Store Nord (GNNDY) Denmark $2.272B 18.82
QuidelOrtho (QDEL) United States $1.916B 13.18
LeMaitre Vascular (LMAT) United States $1.846B 41.26
AtriCure (ATRC) United States $1.565B 0.00
Acuren (TIC) United States $1.335B 0.00
AdaptHealth (AHCO) United States $1.144B 11.62
Neogen (NEOG) United States $1.083B 13.86
Green Thumb Industries (GTBIF) United States $1.059B 23.81
BioLife Solutions (BLFS) United States $1.022B 0.00
Phibro Animal Health (PAHC) United States $0.971B 12.41
InMode (INMD) Israel $0.843B 8.50
Kestra Medical Technologies (KMTS) United States $0.796B 0.00
CeriBell (CBLL) United States $0.643B 0.00
Evolus (EOLS) United States $0.600B 0.00
Owens & Minor (OMI) United States $0.576B 4.78
Curaleaf Holdings (CURLF) Canada $0.547B 0.00
Capricor Therapeutics (CAPR) United States $0.545B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.512B 0.00
Valneva SE (VALN) France $0.487B 0.00
Surmodics (SRDX) United States $0.417B 0.00
Tilray Brands (TLRY) Canada $0.386B 0.00
SNDL (SNDL) Canada $0.334B 0.00
VAREX IMAGING (VREX) United States $0.316B 11.62
SEMPERIT AG HLD (SEIGY) Austria $0.307B 0.00
Sanuwave Health (SNWV) United States $0.282B 0.00
Aurora Cannabis (ACB) Canada $0.263B 78.00
Viemed Healthcare (VMD) United States $0.260B 21.93
Cerus (CERS) United States $0.256B 0.00
Quanterix (QTRX) United States $0.248B 0.00
Sanara MedTech (SMTI) United States $0.245B 0.00
ZimVie (ZIMV) United States $0.240B 10.90
Canopy Growth (CGC) Canada $0.237B 0.00
Cresco Labs (CRLBF) United States $0.236B 0.00
Biote (BTMD) United States $0.218B 6.14
OraSure Technologies (OSUR) United States $0.215B 0.00
Brainsway (BWAY) Israel $0.208B 55.15
TriSalus Life Sciences (TLSI) United States $0.204B 0.00
Verano Holdings (VRNOF) United States $0.192B 0.00
Omeros (OMER) United States $0.189B 0.00
High Tide (HITI) Canada $0.178B 0.00
Organigram Global (OGI) Canada $0.177B 0.00
Utah Medical Products (UTMD) United States $0.174B 14.20
Exagen (XGN) United States $0.157B 0.00
Vireo Growth (VREOF) United States $0.133B 0.00
FitLife Brands (FTLF) United States $0.128B 15.76
Jin Medical (ZJYL) China $0.110B 0.00
Veru (VERU) United States $0.089B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.088B 0.00
Fonar (FONR) United States $0.087B 11.25
MacroGenics (MGNX) United States $0.086B 0.00
Quipt Home Medical (QIPT) United States $0.078B 0.00
TerrAscend (TSNDF) Canada $0.077B 0.00
Agape ATP (ATPC) $0.076B 0.00
Zynex (ZYXI) United States $0.073B 0.00
Cytosorbents (CTSO) United States $0.073B 0.00
InterCure (INCR) Israel $0.068B 0.00
Apyx Medical (APYX) United States $0.065B 0.00
Jushi Holdings (JUSHF) United States $0.057B 0.00
ImmuCell (ICCC) United States $0.055B 0.00
Modular Medical (MODD) United States $0.044B 0.00
Nephros (NEPH) United States $0.038B 51.14
United-Guardian (UG) United States $0.038B 12.98
Rockwell Medical (RMTI) United States $0.032B 0.00
Safety Shot (SHOT) United States $0.023B 0.00
Allurion Technologies (ALUR) United States $0.018B 0.00
Cellectar Biosciences (CLRB) United States $0.017B 0.00
Flora Growth (FLGC) United States $0.016B 0.00
INLIF (INLF) $0.013B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.010B 0.00
Senestech (SNES) United States $0.008B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
IM Cannabis (IMCC) Canada $0.007B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00